The company is developing a drug to treat traumatic brain injury using a molecule extracted from marine macroalgae. This molecule targets the immune system to promote repair after brain trauma. The therapy aims to reduce stimulate the immune cells and enhance neurological recovery. We also work to valorise extraction by-products, ensuring a sustainable, biotech-driven approach to neurorepair. Expertise is sought in polysaccharide chemistry and extraction of molecules at pharmaceutical grade.
Ref. BOTR20260811030 Fabricante textil turco ofrece tejidos innovadores y sostenibles a socios internacionales.
A Turkish textile manufacturer offers innovative and functional fabrics developed for fashion, apparel and interior applications. Combining accredited production facilities, strong R&D capabilities and a sustainability-oriented manufacturing approach, the...
Sep 15, 2026
















